TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
UnitedHealth ( (UNH) ) just unveiled an announcement.
On November 18, 2025, UnitedHealth Group announced the appointment of Scott Gottlieb, M.D. as an independent director. Dr. Gottlieb, known for his tenure as FDA commissioner from 2017 to 2019, is recognized for his efforts in promoting transparency, patient safety, and medical innovation. His appointment is expected to bring valuable insights to UnitedHealth, given his extensive experience in healthcare policy and regulation.
The most recent analyst rating on (UNH) stock is a Hold with a $335.00 price target. To see the full list of analyst forecasts on UnitedHealth stock, see the UNH Stock Forecast page.
Spark’s Take on UNH Stock
According to Spark, TipRanks’ AI Analyst, UNH is a Neutral.
UnitedHealth’s overall stock score reflects strong financial performance and strategic initiatives aimed at long-term growth. However, technical analysis indicates bearish momentum, and valuation metrics suggest the stock is fairly valued. Earnings call insights reveal challenges in managing high medical costs and membership declines, which could impact near-term performance. The company’s focus on operational improvements and strategic realignments is crucial for future success.
To see Spark’s full report on UNH stock, click here.
More about UnitedHealth
Average Trading Volume: 10,464,996
Technical Sentiment Signal: Strong Sell
Current Market Cap: $280B
See more data about UNH stock on TipRanks’ Stock Analysis page.